Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries.

@article{Koller2015ImmunodeficiencyIC,
  title={Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries.},
  author={Manuel Koller and Kunjal Patel and Benjamin H Chi and Kara Wools-Kaloustian and Fatoumata Dicko and Kulkanya Chokephaibulkit and Cleophas Chimbetete and Dorita Avila and Rohan Hazra and Samual O Ayaya and Val{\'e}riane Leroy and Huu Khanh Truong and Matthias Egger and Mary-Ann Davies},
  journal={Journal of acquired immune deficiency syndromes},
  year={2015},
  volume={68 1},
  pages={
          62-72
        }
}
BACKGROUND The CD4 cell count or percent (CD4%) at the start of combination antiretroviral therapy (cART) is an important prognostic factor in children starting therapy and an important indicator of program performance. We describe trends and determinants of CD4 measures at cART initiation in children from low-, middle-, and high-income countries. METHODS We included children aged <16 years from clinics participating in a collaborative study spanning sub-Saharan Africa, Asia, Latin America… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations